Stock Market News
Latest financial news · Updated May 23, 2026
Truist Lowers Synchrony Financial (SYF) Price Target to $71
Analysts disagree on Synchrony Financial's (SYF) outlook, with some citing higher cost of equity and lower market multiples as reasons …
Netflix (NFLX) Raises Subscription Prices
Panelists debate Netflix's pricing strategy, with some bullish on its ability to offset content costs and drive revenue growth, while …
TD Cowen Lowers American Express (AXP) Price Target to $330
Analysts disagree on the impact of macroeconomic factors on American Express (AXP), with some highlighting risks such as potential slowdown …
Fox Corporation (FOXA) in Advance Talks With Kalshi
The panel is largely bearish on Fox's (FOXA) partnership with Kalshi, citing regulatory uncertainty, reputational risk, and the deal's limited …
Charles Schwab (SCHW) Launches Teen Investor Accounts
The panel is divided on Schwab's (SCHW) recent strategies. While some see the 'Teen Investor' accounts and Forge Global acquisition …
Wolfe Research Upgrades Brinker International (EAT) to Outperform
Analyst upgrades on EAT reflect recent traffic outperformance, but high leverage and reliance on promotions pose significant risks. A consensus …
Carvana surges as Jefferies flags strong unit growth, pricing momentum
The panelists' discussion reveals a mixed sentiment towards Carvana's recent performance, with inventory deceleration and potential liquidity constraints being the …
Crude Oil Prices Retreat on Hopes the Iran War is Near an End
Despite headlines suggesting a 'de-escalation premium', the panel agrees that structural supply disruptions persist, with the Strait of Hormuz remaining …
MercadoLibre's fintech terminates its cryptocurrency Mercado Coin
MercadoLibre's shift from Mercado Coin to Meli Dolar is seen as a strategic pivot towards a more useful financial tool, …
Apellis Pharma Skyrockets on Biogen Deal. Is It Too Late to Chase APLS Stock?
The panel is largely bearish on the APLS-BIIB deal, citing regulatory risks, overpayment concerns, integration challenges, and potential drug issues. …
Carnival Stock Forecast: Headwinds Now, Upside Ahead?
The panel's net takeaway is that while Carnival's (CCL) strong booking visibility and capital return ambitions argue for upside, the …
Options Traders Pick Up Pharma Stock After Eli Lilly Buyout
The panel is divided on the CNTA-LLY acquisition, with concerns about deal risk, overpayment, and clinical execution risk for orexin …